Abstract
A reporter gene is a gene type that investigators assigned to a regulatory sequence of another gene of importance in cell cultures, bacteria, plants, or animals. Specific genes are selected as reporters due to their specific traits. Reporter genes can also be employed to assay the expression of a gene that may produce proteins.
Rising funding for cell-based studies, growing inclination toward cell-based assays, rapidly rising applications of gene expression, increasing cancer cases, escalating demand for tailored medicines, and accelerating funding processes from government agencies will drive the reporter gene assay market globally. Increasing R&D activities and growing focus on technological innovation will generate more growth opportunities for the reporter gene assay market. However, the high research cost of cell biology, absence of skilled researchers, the dearth of latest healthcare infrastructure in developing nations, and the lack of awareness may restrict the reporter gene assay market growth globally.
The reporter gene assay market is split based on product, end-user, and application. By product, the reporter gene assay market includes assay kits and reagents. Assay kits are expected to show the highest CAGR over the estimated time period, owing to their recurrent use in studies related to gene expression and signaling pathway exploration along with benefits offered by assay kits above standalone reagents. The end-user segment includes biotechnology and pharmaceutical companies, research and academic institutes, hospital and diagnostic laboratories, and contract research organizations. Biotechnology and pharmaceutical companies dominated the market in 2018. The application segment includes promoter structural and functional analysis, cell signaling pathways, protein interaction, and gene regulation.
North America will lead the reporter gene assay market globally over the forecast time period. The region accounted for over 39% of the global market in 2018, due to the major funding for life sciences studies, growing applications of personalized medicines, rapidly rising cell-based investigation activities, availability of modern healthcare facilities, and the early acceptance of latest technologies. Europe holds the second spot of the global market, due to the presence of trained researchers, huge R&D funding by major companies, rising geriatric population, increasing chronic disorder occurrences, and positive reimbursement scenario. The Asia Pacific reporter gene assay market will grow rapidly over the estimated time period, owing to the rising chronic diseases incidences, growing interest in reporter gene assay, and increasing R&D related to gene therapy.
Some key players of the reporter gene assay market are Thermo Fisher Scientific, Merck, PerkinElmer, Promega Corporation, Abcam, Biotium, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Geno Technology, InvivoGen, Genecopoeia, PromoCell, Lonza Group, Cell Signaling Technology, and General Electric.
This report segments the global reporter gene assay market into:
Global Reporter Gene Assay Market: By Product
Assay Kits
Fluorescent Protein-linked
Luciferase Assay
Secreted Embryonic Alkaline Phosphatase
Beta-galactosidase Assay
Chloramphenicol Acetyltransferase Assay
Others
Reagents
Global Reporter Gene Assay Market: By End-User
Biotechnology and Pharmaceutical Companies
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Contract Research Organizations
Global Reporter Gene Assay Market: By Application
Promoter Structural and Functional Analysis
Cell Signaling Pathways
Protein Interaction
Gene Regulation
Global Reporter Gene Assay Market: By Region
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa